PUBLISHER: GlobalData | PRODUCT CODE: 1464693
PUBLISHER: GlobalData | PRODUCT CODE: 1464693
PCR Systems Market Size by Segments, Share, Regulatory, Reimbursement, Installed Base and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
The model discusses in detail the impact of COVID-19 on PCR Systems market for the year 2020 and beyond. PCR Systems are used for diagnosis and screening of a wide array of infectious disease as well as for testing of cancer patients and hereditary diseases. Nucleic acid amplification tests (NAAT) and PCR systems are frequently used to screen for cytomegalovirus (CMV), human papilloma virus (HPV), mycobacterium tuberculosis, chlamydia trachomatis, hepatitis, and human immunodeficiency virus (HIV).
Segments of PCR systems include Semi Automated qPCR Systems, Automated qPCR Systems, Point of Care (POC) qPCR Systems and Digital PCR Systems.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with installed base. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed PCR Systems and evolving competitive landscape:
Global, Regional and Country level market specific insights:
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Qiagen NV, Abbott Laboratories, bioMerieux Inc, Becton Dickinson and Co, Siemens AG, Danaher Corp, Standard BioTools Inc, Hologic Inc, and Others
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for:
The model will enable you to:
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.